alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Department of Health and Human Services

Substance Abuse and Mental Health Services Administration

Center for Substance Abuse Prevention

National Laboratory Certification Program (NLCP) 

HHS-Certified Laboratory and Instrumented Initial Testing Facility Notice 

Date: December 27, 2017

Subject: Fee Schedule

This notice provides the new fee schedule for laboratories and instrumented initial 

testing facilities (IITFs) participating in or applying for certification in the Department of 

Health and Human Services’ (HHS) National Laboratory Certification Program (NLCP). 

The new fee schedule is effective January 1, 2018. 

The NLCP is a self-supporting program and each participant test facility (i.e., laboratory 

or IITF) is required to pay fees. To maintain this self-supporting certification program, 

the Substance Abuse and Mental Health Services Administration (SAMHSA) Division of 

Workplace Programs (DWP) periodically reviews all costs associated with the 

inspection and performance testing (PT) programs. Every effort is made to ensure that 

the NLCP is a self-supporting program and that each test facility pays fees 

commensurate with the costs of each part of the program.

The following summarizes the changes that are to be effective on January 1, 2018:

1. The NLCP application fee for both laboratories and instrumented initial testing 

facilities (IITFs) has been increased from $2,000 to $3,000. 

2. NLCP fees for laboratories and IITFs have been established for each phase of 

the inspection program and represent an increase of 15%.

3. In addition, RTI has added a new laboratory category, Category 6. Since 

SAMHSA established Categories 0 through 5, the workloads of some certified 

laboratories have increased such that the current inspection format is not 

sufficient to enable review of the target percentage (i.e., about 10%) of the 

laboratory’s non-negative specimens. Laboratories will continue to be notified of 

their category changes.

If you have any questions regarding these changes, please contact me at (240) 276-

2600 or by email: Ron.Flegel@samhsa.hhs.gov. 

Ron Flegel 

Director 

Division of Workplace Programs

 Ron Flegel
The NLCP Fee Schedule, effective January 1, 2018 is as follows for 

Laboratories and Instrumented Initial Testing Facilities:

Event Fee ($)

Application $3,000 

Inspections

Initial $12,900 

3-month Second Initial $12,900 

Maintenance

IITF $12,900 

Laboratory:

Category 0 $10,400 

Category 1 $12,900 

Category 2 $18,800 

Category 3 $28,500 

Category 4 $43,700 

Category 5 - Inspection $43,700 

Category 5- Audit $28,500 

Category 6 - Inspection $54,600 

Category 6- Audit $39,400 

Special Inspection Actual Cost

Remedial Action:

Pre-inspection $1,000 

Post-inspection $3,000 

Performance Testing

Initial Set $3,000 

Maintenance Set $3,000 

Remedial Action:

Major $3,000 

Reoccurring Minor $1,000 

Withdrawal - Final Audit Inspection Actual Cost

The fee schedule will continue to be evaluated periodically to ensure fees accurately 

reflect the costs associated with each activity.
SAMHSA/CSAT Grant (2011-2016): $8,330,000

**Program Description**

The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance 

Abuse Treatment (CSAT) awarded the Department of Social and Health Services (DSHS) - Division of Behavioral Health and Recovery (DBHR) the five year Screening, Brief Intervention, and Referral to Treatment (SBIRT) grant in September of 2011. Washington’s goals with this grant have been to disseminate, implement and sustain SBIRT services in the Primary Care settings throughout the State. The Washington State SBIRT-Primary Care Integration (WASBIRT-PCI) project is responsible for program implementation and monitoring; information dissemination; and creating a sustainable, reimbursable SBIRT program. SBIRT is an evidence-based public health practice based on universal alcohol and drug screening to increase awareness about an important preventable health issue - substance abuse.  

**Program Model**

WASBIRT-PCI is currently offering SBIRT services to adults receiving primary care and emergent care in the following counties:  King, Whitman, Cowlitz and Clallam County. The project integrates behavioral and primary health care and has worked to create a sustainable reimbursement system for SBIRT under Medicaid. In an effort to disseminate SBIRT broadly, WASBIRT-PCI funds clinic sites for 12-18 months.  During this time we assist them with training, technical assistance, and creating a sustainable clinical practice. The intent of the project has been to disseminate SBIRT statewide by providing comprehensive training to grantee and non-grantee sites and develop protocols for SBIRT reimbursement to sustain the program statewide.

**Special/Unique Features**

Some unique features of WASBIRT-PCI include:

· Mixture of grant funded clinics and hospitals that are urban and rural.

· Funding an FQHC in King County who specializes in services for the Latino population.  

· Funding a clinic that is operated by Jamestown/S’Klallam Tribe, which serves over 300 tribal members.

· Developed the Screening, Performance and Results (SPAR) electronic data collection tool for GPRA data collection, with cross-checks and validation standards that allows for timely, secure data transfer. 

· WASBIRT-PCI has facilitated partnerships between community emergency departments and primary care clinics to enhance the continuum of care for patients identified as having some level of substance use disorder.  

**Website URL**: http://www.wasbirt.com/

**Contact Information**

Name:  James A. Oliver Name: Elizabeth Speaker Lee

Title:  WASBIRT-PCI Project DirectorTitle: WASBIRT-PCI Project Research Manager

Address 1:  P.O. Box 45330 Address 1:  P.O. Box 45330

City, State, Zip:  Olympia, WA 98504-5330City, State, Zip:  Olympia, WA 98504-5330

Phone Number:  360-725-2290Phone Number:  360-725-1715

Fax Number:  360-725-2279Fax Number:  360-725-2279

Email Address:  james.oliver@dshs.wa.govEmail Address:  speakec@dshs.wa.gov
EXHIBIT 31.2
FORM OF SARBANES-OXLEY SECTION 302(a) CERTIFICATION
I, Chad C. Braun, Chief Financial Officer, certify that:
 1.  I have reviewed this annual report on Form 10-K of AmREIT;  2.  Based on my knowledge, this annual report does not contain any untrue statement of amaterial fact or omit to state a material fact necessary to make the statements made, inlight of the circumstances under which such statements were made, not misleading withrespect to the period covered by this annual report;  3.  Based on my knowledge, the financial statements, and other financial information includedin this annual report, fairly present in all material respects the consolidated financialcondition, results of operations and cash flows of the registrant as of, and for, theperiods presented in this annual report;  4.  The registrant’s other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 and15d-15) for the registrant and we have:
               i. designed such disclosure controls and procedures to ensure that material informationrelating to the registrant, including its consolidated subsidiaries, is made known to us by otherswithin those entities, particularly during the period in which this annual report is beingprepared;
               ii. evaluated the effectiveness of the registrant’s disclosure controls and procedures as ofa date within 90 days prior to the filing date of this annual report (the “Evaluation Date”); and
               iii. presented in this annual report our conclusions about the effectiveness of thedisclosure controls and procedures based on our evaluation as of the Evaluation Date;
 5.  The registrant’s other certifying officer and I have disclosed, based on our most recentevaluation, to the registrant’s auditors and the audit committee of registrant’s board oftrust managers (or persons performing the equivalent functions):
               i. all significant deficiencies in the design or operation of internal controls which couldaversely affect the registrant’s ability to record, process, summarize and report financial dataand have identified for the registrant’s auditors any material weaknesses in internal controls; and
               ii. any fraud, whether or not material, that involves management or other employees who havea significant role in the registrant’s internal controls; and
 6.  The registrant’s other certifying officer and I have indicated in this annual reportwhether or not there were significant changes in internal controls or in other factors thatcould significantly affect internal controls subsequent to the date of our most recentevaluation, including any corrective actions with regard to significant deficiencies andmaterial weaknesses.        Date: March 31, 2005 By:  /s/ Chad C. Braun   Chad C. Braun, Chief Financial Officer       
34
#### § 401.31 Scope.

This subpart shall govern the submission and review of projects under Section 3.8 of the Delaware River Basin Compact.
#### § 10.9 Requirements for supplemental registration statement.

The rules and regulations in this part with respect to registration statements submitted to the Attorney General under section 2 of the said act shall apply with equal force and effect to supplemental registration statements required thereunder to be filed with the Attorney General.
### SUBCHAPTER LXX—OZARK NATIONAL SCENIC RIVERWAYS
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

      ( print page 14037)    
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App), notice is hereby given of a meeting of the Biomedical Library and Informatics Review Committee.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Biomedical Library and Informatics Review Committee.                    

*Date:*                         June 9, 2011.                    

*Time:*                         June 9, 2011, 8 a.m. to 6 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Library of Medicine, Building 38, 2nd Floor, Board Room, 8600 Rockville Pike, Bethesda, MD 20892.                    

*Time:*                         June 10, 2011, 8 a.m. to 2 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Contact Person:*                         Arthur A. Petrosian, PhD, Chief Scientific Review Officer, Division of Extramural Programs, National Library of Medicine, 6705 Rockledge Drive, Suite 301, Bethesda, MD 20892-7968, 301-496-4253,                         *petrosia@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program No. 93.879, Medical Library Assistance, National Institutes of Health, HHS)

Dated: March 9, 2011.

Jennifer S. Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2011-6027 Filed 3-14-11; 8:45 am]

BILLING CODE 4140-01-P
<PAGE>
ARTICLE 5

THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE 
UNAUDITED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 1998 AND 
IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.

RESTATED
MULTIPLIER 1,000
<TABLE>
<S>                             <C>
PERIOD-TYPE                   6-MOS
FISCAL-YEAR-END                          DEC-31-1998
PERIOD-START                             JAN-01-1998
PERIOD-END                               JUN-30-1998
CASH                                             378
SECURITIES                                         0
RECEIVABLES                                    1,394
ALLOWANCES                                         0
INVENTORY                                          0
CURRENT-ASSETS                                 1,776
PP&E                                          11,894
DEPRECIATION                                   (991)
TOTAL-ASSETS                                  13,724
CURRENT-LIABILITIES                           13,011
BONDS                                              0
PREFERRED-MANDATORY                                0
PREFERRED                                          0
COMMON                                             0
OTHER-SE                                         543
TOTAL-LIABILITY-AND-EQUITY                    13,724
SALES                                              0
TOTAL-REVENUES                                 2,551
CGS                                              114
TOTAL-COSTS                                      727
OTHER-EXPENSES                                     0
LOSS-PROVISION                                     0
INTEREST-EXPENSE                                 409
INCOME-PRETAX                                  1,415
INCOME-TAX                                       545
INCOME-CONTINUING                                870
DISCONTINUED                                       0
EXTRAORDINARY                                      0
CHANGES                                            0
NET-INCOME                                       870
EPS-PRIMARY                                        0
EPS-DILUTED                                        0
</TABLE>
Comment Info: =================

General Comment:
## Court of Appeals Sixth Appellate District of Texas

J U D G M E N T

Ex parte Manuel Flores, Jr.

No. 06

- 20

- 00124

- CR Appeal from the 54th District Court of McLennan County, Texas (Tr. Ct

. No. 2020

- 2233

- 2 ). Memorandum Opinion delivered by Justic e Stevens
, Chief Justice Morriss and Justice Burgess participating

.

As stated in the Court’s opinion of this date, we find no error in the judgment of the court below. We affirm the judgment of the trial court. We note that the appellant, Manu el Flores, Jr. , has adequately indicated his inability to pay costs of appeal. Therefore, we waive payment of costs.

RENDERED FEBRUARY 2 6 , 2021 BY ORDER OF THE COURT JOSH R. MORRISS, III CHIEF JUSTICE

ATTEST: Debra K. Autrey , Clerk
# C_2011319EN.01000902.xml

| 29.10.2011 | EN | Official Journal of the European Union | C 319/9 |
| --- | --- | --- | --- |

29.10.2011

EN

Official Journal of the European Union

C 319/9

---

Appeal brought on 3 March 2011 by Ignacio Ruipérez Aguirre and ATC Petition against the judgment of the General Court (Fourth Chamber) delivered on 20 January 2011 in Case T-487/10 Ignacio Ruipérez Aguirre and ATC Petition v European Commission

(Case C-111/11 P)

2011/C 319/15

Language of the case: Spanish

Parties

Parties

Appellants: Ignacio Ruipérez Aguirre and ATC Petition (represented by: M.J. Sánchez González, abogada)

Appellants:

Other party to the proceedings: European Commission

Other party to the proceedings:

By order of 14 July 2011, the Court of Justice (Sixth Chamber) dismissed the appeal.

---
#### § 367.4010 Account 401, Operation expense.

There must be shown under this caption the total amount included in the service company operation expense accounts 500 through 589 (§§ 367.5000 through 367.5890), 800 through 881 (§§ 367.8000 through 367.8810) and 901 through 931 (§§ 367.9010 through 367.9310).
**EXHIBIT 32.2**

CERTIFICATE PURSUANT TO18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the report of Prospect MedicalHoldings, Inc. (the “Company”) on Form 10-Q for the period ended December 31,2006 (the “Report”), I, Mike Heather, Chief Financial Officer of the Company,certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements ofSection 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairlypresents, in all material respects, the financial condition and results ofoperations of the Company.
| February 14, 2007 | /s/ MIKE HEATHER            |
|-------------------|-----------------------------|
|              | **Mike Heather**            |
|              | **Chief Financial Officer** |

 

----
Exhibit 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In connection with the quarterly report of GoAmerica, Inc. (the "Company")
on Form 10-Q for the quarter ended March 31, 2007 filed with the  Securities and
Exchange  Commission  (the  "Report"),  I, Donald G. Barnhart,  Chief  Financial
Officer of the Company,  certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully  complies  with the  requirements  of Section  13(a) of the
Securities Exchange Act of 1934; and

(2) The  information  contained in the Report fairly  presents,  in all material
respects,  the consolidated  financial  condition of the Company as of the dates
presented and consolidated  results of operations of the Company for the periods
presented.

Dated: May 15, 2007

                                                      /s/ Donald G. Barnhart
                                                      ------------------------
                                                      Donald G. Barnhart
                                                      Chief Financial Officer

This  certification  has been  furnished  solely  pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.


                                      -22-
1The Honorable John R. Tunheim, United States District Judge for the District

of Minnesota.

United States Court of Appeals

FOR THE EIGHTH CIRCUIT

_____________

No. 00-2675MN

_____________

United States of America, *

* On Appeal from the United

Appellee, * States District Court

* for the District

v. * of Minnesota.

* 

Alberto Ramirez-Bandrich, * [Not To Be Published]

*

Appellant. *

___________

 Submitted: May 31, 2001

 Filed: June 8, 2001

___________

Before MORRIS SHEPPARD ARNOLD, RICHARD S. ARNOLD, and FAGG,

Circuit Judges.

___________

PER CURIAM.

Alberto Ramirez-Bandrich pleaded guilty to reentering the United States illegally

after previously having been convicted of an aggravated felony and deported, in

violation of 8 U.S.C. §§ 1326(a) and (b)(2). The District Court1 departed downward

and sentenced Ramirez-Bandrich to three years and ten months (forty-six months)

imprisonment and three years supervised release, and he appeals. His counsel has filed
-2-

a brief and has moved to withdraw pursuant to Anders v. California, 386 U.S. 738

(1967). Although we granted Ramirez-Bandrich permission to file a pro se

supplemental brief, he has not done so.

As part of his written plea agreement, Ramirez-Bandrich waived the right to

appeal this sentence, and we conclude that the waiver was knowing and voluntary.

Ramirez-Bandrich was assisted by counsel and an interpreter at the change-of-plea and

sentencing hearings; the Court carefully questioned him about the appeal waiver at the

change-of-plea hearing, verifying that he understood it; the Court advised him of the

statutory maximum penalty; and his sentence was consistent with the plea agreement.

See United States v. Michelsen, 141 F.3d 867, 871-72 (8th Cir.) (holding that appeal

waiver is enforceable so long as it resulted from knowing and voluntary decision), cert.

denied, 525 U.S. 942 (1998); United States v. Greger, 98 F.3d 1080, 1081-82 (8th

Cir.1996) (enforcing knowing and voluntary waiver of right to appeal sentence so long

as sentence is not in conflict with negotiated plea agreement; waiver was knowing and

intelligent where it was included in plea agreement and was discussed at change-of-plea

hearing).

Accordingly, because Ramirez-Bandrich’s sentence was not in conflict with the

plea agreement, we now specifically enforce his promise not to appeal by dismissing

this appeal. See United States v. Estrada-Bahena, 201 F.3d 1070, 1071 (8th Cir. 2000)

(per curiam). We also grant counsel’s motion to withdraw.

A true copy.

Attest:

CLERK, U.S. COURT OF APPEALS, EIGHTH CIRCUIT.
Employment offer letter to Phillip Rose


 Exhibit 10.1 
 May 22, 2008 
 Phillip Rose 
 [Address]

 Dear Phil, 
 Per our discussions, we would like to take this
opportunity to offer you the position of Chief Operating Officer with our organization. The table below outlines the terms of your employment at Senetek PLC. 
  

			
	Title	 	Chief Operating Officer
		
	Employment Start Date	 	To be discussed with and agreed upon by Frank Massino
		
	Annual Salary	 	$240,000
		
	Equity	 	40,000 Stock Options (at market price on the date of grant)
		
	Report To	 	Frank J. Massino, Chairman & CEO
		
	Location	 	Napa Headquarters or Southern California, subject to discussion and approval with Frank Massino
		
	Bonus Plan	 	Eligible for pro rata participation in Management Bonus Program








			
		
	401K	 	Eligible for enrollment in Company’s 401K plan in accordance with its terms
		
	Employee Benefits	 	Eligible for enrollment in Company’s medical, dental, group life and disability insurance plans effective immediately

 We look forward to having you as a member of our team. 
 Sincerely, 
 Corena Michnevich 
 Vice President, Human Resources 
 Senetek PLC 
  

					
	AGREED TO AND ACCEPTED BY:	 		 	
			
	  	 		 	  
	Phillip Rose	 		 	Date







 Additional Agreed Upon Terms on May 27, 2008: 
  

	 	1.	Senetek to underwrite relocation of automobile and personal items to California (to be kept under $2000). 

  

	 	2.	Senetek to underwrite up to 3 month temporary housing in Napa. 

  

	 	3.	Senetek to provide necessary equipment such as Blackberry or laptop computer. 

  

	 	4.	Senetek to include a 2 month severance package – in the event employee is terminated for anything other than cause.